| |
Thu. 09/27 Focus Heart |
| |
KTS
Cardiovascular |
KMS
Apheresis |
OS
Biomaterials |
WS 1
Others |
| 8.30 to 10.00 |
Session
T. 1
CV Tissue Engineering I |
Session
T. 5
Apheresis in Cardiovascular Diseases |
Session
T. 9
Cell Biomaterial Interaction |
Session
T. 13
Minimal inavasive monitoring in kidney dialyses |
| |
| 10.30 to 12.30 |
Session
T. 2
CV Tissue Engineering II |
Session
T. 6
Apheresis in Cardiovascular Diseases II |
Session
T. 10
Assessment of Biomaterial Properties |
Session
T. 14
Extracorporal Treatment of Sepsis |
| |
| |
Postersession I (P1-P16) |
Postersession I (P17-P20) |
Postersession I (P21-P29) |
|
| |
| 2.00 to 3.30 |
Session
T. 3
CV Stem cells |
Session
T. 7
Experimentel Apheresis |
Session
T. 11
Design and Synthesis of Biomaterials |
Session
T. 15
Pediatric extracorporeal perfusion and assist device |
| |
| 4.00 to 6.00 |
Session
T. 4
CV Biomaterial & Perfusion |
Session
T. 8
Immune Apheresis |
Session
T. 12
Immune Apheresis |
Session
T. 16
Horizon 2020; Future of biomedical engineering: EU funding |
